Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)		1 Months Ended		12 Months Ended
	Dec. 07, 2017	Jan. 31, 2018	Mar. 30, 2016	Dec. 31, 2017	Dec. 31, 2016
Summary Of Significant Accounting Policies [Line Items]
Expected term					2 years 9 months
Risk free interest rate					1.47%
Expected volatility rate					53.01%
Health Care Organization, Patient Service Revenue				$ 11,712,965	$ 9,163,970
Cash, Uninsured Amount				135,300,000	74,200,000
Restricted Cash				18,005,661	101,132
Increase in Restricted Cash				18,000,000	0
Marketable Securities, Current				1,143,095	1,051,807
Allowance for Doubtful Accounts Receivable, Current				407,953	0
Derivative Asset, Noncurrent				0	5,338,886
Goodwill and Intangible Asset Impairment, Total				$ 2,431,791	324,306
Goodwill, Impairment Loss					316,610
Equity Method Investment, Significant Influence Description				Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s board of directors, are considered in determining whether the equity method of accounting is appropriate.
Restricted Cash, Noncurrent				$ 745,235	0
Assets Held-in-trust, Current				2,017,437	1,050,739
Provision for Loss on Contracts				0	$ 0
Subsequent Event [Member]
Summary Of Significant Accounting Policies [Line Items]
Payment Of Revenue		$ 7,300,000
Professional Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue				20,000
Medi-Cal Patients Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue				$ 200,000
Warrant Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Expected term					5 years
Risk free interest rate	1.90%		1.20%
Expected volatility rate			69.90%
Share Price	$ 9.99		$ 5.93		$ 7.50
Percentage For Down round financing	0.00%		0.00%		0.00%
Financial Liabilities Fair Value Disclosure			$ 1,500,000
Derivative Asset, Noncurrent	$ 5,300,000				$ 5,300,000
Maximum
Summary Of Significant Accounting Policies [Line Items]
Expected term				1 year 9 months
Risk free interest rate				1.86%
Expected volatility rate				41.60%
Share Price				$ 0.76	$ 0.76
Restricted Cash Interest Rate				0.10%
Marketable Securities Maturity Period				12 years
Maximum | Warrant Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Expected term				3 years 3 months 22 days	4 years 2 months 26 days
Risk free interest rate					1.76%
Expected volatility rate	40.26%				63.00%
Minimum
Summary Of Significant Accounting Policies [Line Items]
Expected term				11 months 5 days
Risk free interest rate				1.64%
Expected volatility rate				38.10%
Share Price				$ 0.52	$ 0.52
Restricted Cash Interest Rate				0.05%
Marketable Securities Maturity Period				4 years
Minimum | Warrant Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Expected term				2 years 10 months 6 days	3 years 9 months 14 days
Risk free interest rate					1.67%
Expected volatility rate	39.24%				62.50%
APA ACO [Member]
Summary Of Significant Accounting Policies [Line Items]
Estimated Revenue Percentage				100.00%
APC [Member] | Professional Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue				$ 60,000
MMG [Member] | Professional Stop Loss [Member]
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue				$ 50,000